Literature DB >> 29087771

Antithymocyte Globulin for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation.

Mohamad Mohty1, Florent Malard1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29087771     DOI： 10.1200/JCO.2017.76.0512

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  A pilot study of single nucleotide polymorphisms in the interleukin-6 receptor and their effects on pre- and post-transplant serum mediator level and outcome after allogeneic stem cell transplantation.

Authors:  T H A Tvedt; R Hovland; G Tsykunova; A B Ahmed; T Gedde-Dahl; Ø Bruserud
Journal:  Clin Exp Immunol       Date:  2018-04-01       Impact factor: 4.330

2.  Impact of anti-thymocyte globulin dose for graft-versus-host disease prophylaxis in allogeneic hematopoietic cell transplantation from matched unrelated donors: a multicenter experience.

Authors:  Sara Butera; Marco Cerrano; Lucia Brunello; Chiara Maria Dellacasa; Danilo Giuseppe Faraci; Sara Vassallo; Nicola Mordini; Roberto Sorasio; Francesco Zallio; Alessandro Busca; Benedetto Bruno; Luisa Giaccone
Journal:  Ann Hematol       Date:  2021-05-04       Impact factor: 3.673

3.  Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC.

Authors:  Florent Malard; Myriam Labopin; Christina Cho; Didier Blaise; Esperanza B Papadopoulos; Jakob Passweg; Richard O'Reilly; Edouard Forcade; Molly Maloy; Liisa Volin; Hugo Castro-Malaspina; Yosr Hicheri; Ann A Jakubowski; Corentin Orvain; Sergio Giralt; Mohamad Mohty; Arnon Nagler; Miguel-Angel Perales
Journal:  J Hematol Oncol       Date:  2018-10-20       Impact factor: 17.388

Review 4.  Anti-thymocyte globulin in haematology: Recent developments.

Authors:  Salahuddin Siddiqui; Jessica Cox; Roger Herzig; Senthilnathan Palaniyandi; Gerhard C Hildebrandt; Reinhold Munker
Journal:  Indian J Med Res       Date:  2019-09       Impact factor: 2.375
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.